気管支喘息治療のストラテジー ―病態・疫学・診断・日常管理―

出版社： 先端医学社
著者：
発行日： 2001-11-10
分野： 臨床医学：内科  >  呼吸器一般
ISBN： 9784884070458
電子書籍版： 2001-11-10 （第1版第1刷）
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,090 円(税込)

購入する

商品紹介

疾患を多方面からのアプローチでとらえ、日常臨床で必要な薬剤の効果的かつ適切な使用法等、治療戦略に不可欠な情報を提示
気管支喘息の治療を行ううえで臨床医が知っておくべき内容を「病態・疫学・診断・日常管理」の面からわかりやすく解説．医療経済的側面や、問診のポイント、鑑別のポイント、患者への日常管理の指導法など有益な情報を含み、従来の喘息に関する医学書ではふれられなかった点を重点的に論じるセンセーショナルな一冊。

目次

  • 表紙
  • 序文
  • 執筆者一覧(掲載順)
  • 目次
  • PART 1 / 病態生理研究の進歩
  • ☆ 気道炎症としての気管支喘息
  • ☆ 気管支喘息と化学伝達物質(とくにロイコトリエン)
  • ☆ 気管支喘息と気道リモデリング
  • PART 2 / 気管支喘息の疫学
  • ☆ 気管支喘息の罹患率・有症率・背景因子に変化はあるか
  • ☆ 医療経済学からみた気管支喘息治療の現状と課題
  • PART 3 / 気管支喘息の発症因子・誘発因子
  • ☆ 気管支喘息の誘発因子は何か
  • ☆ 気管支喘息とウイルス感染症
  • ☆ 喫煙は気管支喘息にいかに関与しているか
  • ☆ ディーゼルエンジン由来粒子状物質は気管支喘息発症にいかに関与しているか
  • ☆ ストレスは気管支喘息にいかに関与しているか
  • PART 4 / 気管支喘息の診断
  • ☆ 気管支喘息の診断手順の基準
  • ☆ 気管支喘息の問診のポイント
  • ☆ 気管支喘息の診断・肺機能検査の重要性
  • ☆ 気管支喘息と他疾患との鑑別診断のポイント
  • ☆ 小児気管支喘息の診断と治療のポイント～小児のアレルギー性疾患～
  • PART 5 / 気管支喘息の日常管理法と治療への応用
  • ☆ 気管支喘息の患者教育はなぜ重要か
  • ☆ 小児気管支喘息の患者教育のポイントをどこへ置くか
  • ☆ 喘息教室 / 喘息学級の試み
  • ☆ 施設入院療法への応用
  • ☆ ピークフローモニタリングの意義
  • ☆ 喘息児のための運動療法
  • 索引
  • ☆ 和文索引
  • ☆ 欧文索引
  • ☆ 薬剤一覧
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

PART 1 / 病態生理研究の進歩

P.14 掲載の参考文献
1) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン, 牧野荘平ほか監修, 協和企画通信, 東京, 1998, pp32-50
 
2) National Heart, Lung, and Blood Institute, NIH, Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention, NHLBI/WHO Workshop Report, National Institute of Health, Publication Number 95-3659, 1995
 
3)Fukuda T, Toda M, Fukushima Y et al:Airway remodeling in bronchial asthma.ACI International 10:187-192, 1998
 
4) 福田健:喘息における気道炎症. 日内会誌 85:189-193, 1996
 
P.23 掲載の参考文献
1) 茆原順一, 齋藤紀先:気道炎症としての気管支喘息. ロイコトリエンと気管支喘息,.アレルギー, 茆原順一編, 医薬ジャーナル社, 大阪, 1999, pp10-26
 
2) 茆原順一, 山田佳之:気管支喘息における気道の炎症を治療する Part 2 気道炎症を構成する細胞からみた治療法-好酸球-. Mebio 5:33-37, 1999
 
3) Tamura G, Inoue H, Chihara J et al:Population-based open-label clinical effectiveness assessment of the cysteinyl leukotriene receptor antagonist pranlukast. Allergology International 49:189-194, 2000
 
4) Leff AR:Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am J Respir Crit Care Med 161:S125-S132, 2000
PubMed
5) Harkavy J:Spasm-producing substance in the sputum of patients with bronchial asthma. Arch Int Med 45:641-646, 1930
 
6) Jakschik BA Falkenhein S, Parker CW:Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci U S A 74:4577-4581, 1977
PubMed
7) Borgeat P, Samuelsson B:Arachidonic acid metabolism in polymorphonuclear leukocytes:effects of ionophore A23187. Proc Natl Acad Sci U S A 76:2148-2152, 1979
PubMed
8) Drazen JM, Israel E, O'Byrne PM:Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197-206, 1999
PubMed
9) Serhan CN, Haeggstrom JZ, Leslie CC:Lipid mediator networks in cell signaling:update and impact of cytokines. FASEB J 10:1147-1158, 1996
PubMed
10) Hunter JA, Finkbeiner WE, Nadel JA et al:Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A 82:4633-4637, 1985
PubMed
11) Tornhamre S, Sjolinder M, Lindberg A et al:Demonstration of leukotriene-C 4 synthase in platelets and species distribution of the enzyme activity. Eur J Biochem 251:227-235, 1998
PubMed
12) Munoz NM, Hamann KJ, Rabe KF et al:Augmentation of eosinophil degranulation and LTC (4) secretion by integrin-mediated endothelialcell adhesion. Am J Physiol 277:L802-L810, 1999
 
13) Silberstein DS, Owen WF, Gasson JC et al:Enhancement of humane eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol 137:3290-3294, 1986
 
14) Takafuji S, Bischoff SC, De Weck AL et al:IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C 4 in response to soluble agonists. J Immunol 147:3855-3861, 1991
PubMed
15) Yokomizo T, Izumi T, Chang K et al:A G-protein-coupled receptor for leukotriene B 4 that mediates chemotaxis. Nature 387:620-624, 1997
 
16) Lynch KR, O'Neill GP, Liu Q et al:Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399:789-793, 1999
PubMed
17) Nothacker HP, Wang Z, Zhu Y et al:Molecular cloning and characterization of a second human cysteinyl leukotriene receptor:discovery of a subtype selective agonist. Mol Pharmacol 58:1601-1608, 2000
PubMed
18) Figueroa DJ, Breyer RM, Defoe SK et al:Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 163:226-233, 2001
PubMed
19) Thivierge M, Doty M, Johnson J et al:IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. J Immunol 165:5221-5226, 2000
PubMed
20) Sarau HM, Ames RS, Chambers J et al:Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 56:657-663, 1999
PubMed
21) Tager AM, Dufour JH, Goodarzi K et al:BLTR mediates leukotriene B (4)-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis. J Exp Med 192:439-446, 2000
 
22) Foster A, Chan CC:Peptide leukotriene involvement in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig. Int Arch Allergy Appl Immunol 96:279-284, 1991
PubMed
23) Laitinen LA, Laitinen A, Haahtela T et al:Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 341:989-990, 1993
PubMed
24) Diamant Z, Hiltermann JT, van Rensen EL et al:The effect of inhaled leukotriene D 4 and methacholine on sputum cell differentials in asthma. Am J Respir Crit Med 155:1247-1253, 1997
 
25) Fujita M, Nakagawa N, Yonetomi Y et al:Cysteinyl leukotrienes induce nasal symptoms of allergic rhinitis via a receptor-mediated mechanism in guinea pigs. Jpn J Pharmacol 75:355-362, 1997
 
26) Nakamura Y, Hoshino M, Sim JJ et al:Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 53:835-841, 1998
PubMed
27) Spada CS, Krauss AH, Nieves AL et al:Effects of leukotrienes B 4 (LTB 4) and D 4 (LTD 4) on motility of isolated normodense human eosinophils and neutrophils. Adv Exp Med Biol 400B:699-706, 1997
 
28) White MV:The role of histamine in allergic diseases. J Allergy Clin Immunol 86:599-605, 1990
PubMed
29) Breyer RM, Bagdassarian CK, Myers SA et al:Prostanoid receptors:subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661-690, 2001
PubMed
30) Matsuoka T, Hirata M, Tanaka H et al:Prostaglandin D 2 as a mediator of allergic asthma. Science 287:2013-2017, 2000
 
31) Hirai H, Tanaka K, Yoshie O et al:Prostaglandin D 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH 2. J Exp Med 193:255-261, 2001
 
32) Nagata K Tanaka K, Ogawa K et al:Selective expression of a novel surface molecule by human Th 2 cells in vivo. J Immunol 162:1278-1286, 1999
PubMed
33) Myou S, Sano H, Fujimura M et al:Blockade of eosinophil migration and airway hyperresponsiveness by cPLA 2-inhibition. Nat Immunol 2:145-149, 2001
 
34) Chihara J, Urayama O, Kayaba H et al:Inhibitory effect of ibudilast (KC-404) on the expression of the beta 2 integrin family on an eosinophilic cell line (EoL-1). Ann Allergy Asthma Immunol 81:448-450, 1998
 
35) Hayashi N, Chihara J, Kobayashi Y et al:Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion. Int Arch Allergy Immunol 104 (suppl 1):57-59, 1994
 
36) Chihara J, Maruyama I, Yasuba H et al:Possible induction of intercellular adhesion molecule-1(ICAM-1) expression on endothelialcells by platelet-activating factor(PAF). J Lipid Mediat 5:159-162, 1992
 
P.31 掲載の参考文献
1) 大田健:II 病態.生理 2. リモデリング. Medical Topics Series 喘息 '94, 牧野荘平監修, メディカルレビュー社, 東京, 1994, pp34-41
 
2) NHLBI/WHO ワークショップレポート:喘息における気道の病理, in 喘息管理の国際指針. 喘息管理・予防のグローバルストラテジー 日本語版, 牧野荘平監修, 国際医学出版, 東京, 1995, pp2-3
 
3) Shoji S, Ertl RF, Linder J et al:Bronchial epithelial cells respond to insulin and insulin-like growth factor-I as a chemoattractant. Am J Respir Cell Mol Biol 2:553-557, 1990
PubMed
4) Masui T, Wakefield LM, Lechner JF et al:Type βtransforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 83:2438-2442, 1986
 
5) Jetten AM:Multi-step Process of squamous differentiation in tracheobronchial epithelial cells in vitro:analogy with epidermal differentiation. Environ Health Perspect 80:149-160, 1989
 
6) Mautino G, Oliver N, Chanez P et al:Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 17:583-591, 1997
PubMed
7) Vignola AM, Riccobono L, Mirabella A et al:Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care. Med 158:1945-1950, 1998
PubMed
8) Kumagai K, Ohno I, Okada S et al:Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 162:4212-4219, 1999
 
9) Wiggs BR, Bosken C, Pare PD et al:A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 145:1251-1258, 1992
 
10) Saetta M, Maestrelli P, Turato G et al:Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 151:489-494, 1995
PubMed

PART 2 / 気管支喘息の疫学

P.40 掲載の参考文献
1) Sheffer AL:Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 88:1985
 
2) 川上保雄, 芦田昭夫, 高橋昭三ほか:都市生活青壮年者におけるアレルギー性疾患の頻度. 総合医学 14:1096, 1957
 
3) 石崎達, 荒木英斉, 佐々木智也ほか:喘息及びじんましんの疫学的研究 (1) 農村の発生率と素質的解析. アレルギー 10:230, 1962
 
4) 中川武正, 伊藤幸治, 大田健ほか:静岡県藤枝市における成人気管支喘息の有症率調査. 日胸疾会誌 25:873-879, 1987
 
5) 大田健:わが国の各呼吸器疾患の疫学と対策 (3) 気管支喘息. 日本呼吸器学会雑誌 37:19-23, 1999
 
6) 西間三馨:小児気管支喘息福岡市 (公害地区) における調査結果. 14, 1982
 
7) 柳川洋:わが国における喘息患者受療の動向. 日本醫事新報 24:3453-3455, 1990
 
8) 西間三馨:小児気管支喘息. 臨床アレルギー学, 南江堂, 東京, 1992, pp420-430
 
9) 松村竜雄:学童気管支喘息の頻度. 日本醫事新報22:2272-2274, 1967
 
10) 秋山一男, 響庭三代治, 柳川洋ほか:我が国における成人気管支喘息の実態. 日胸疾会誌 29:984, 1991
 
11) 秋山一男, 三上理一郎, 可部順三郎:成人気管支喘息の新しい分類の提唱-小児発症喘息, 成人発症喘息, 成人再発喘息-. アレルギー 41:727-738, 1992
Medical*Online
12) 田部一秋, 秋山一男:気管支喘息の頻度・病型と年齢的変化. 医学のあゆみ 159:539-541, 1991
 
P.46 掲載の参考文献
1) 日本アレルギー学会:喘息の長期管理における薬物療法プラン. アレルギー疾患治療ガイドライン (95年改訂版), 日本アレルギー学会監修, ライフサイエンス・メディカ, 東京, 1995, pp20-29
 
2) Stempel DA, Stanford RH, Thwaites R et al:Cost-efficacy comparison of inhaled fluticasone propionate and budesonide in the treatment of asthma. Clin Ther 22:1562-1574, 2000
PubMed
3) Miyamoto T, Fujino S, Nakajima S et al:Cost-effectiveness of budesonide Turbuhaler in the treatment of mild-to-moderate asthma in Japan. Allergology International 48:275-285, 1999
 
4) Jefferson T, Demicheli V, Mugford M:医療経済学について. シナリオで学ぶ医療経済学入門, 酒井弘憲, 森田智覗訳, サイエンティスト社, 東京, 1992, pp1-9
 
5) Kauppinen R, Vilkka V, Sintonen H et al:Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma. Respir Med 95:56-63, 2001
PubMed

PART 3 / 気管支喘息の発症因子・誘発因子

P.53 掲載の参考文献
1) National Heart, Lung and Blood Institute, Global Initiative for Asthma, Global Strategy For Asthma Management and Prevention, NHLBI/WHO Workshop Report, National Institute of Health, Publication No 95:3659, 1995
 
2) 厚生省免疫.アレルギー研究班:喘息の危険因子. 喘息予防・管理ガイドライン 1998, 牧野荘平, 古庄巻史, 宮本昭正監修, 協和企画通信, 東京, 1998
 
3) Platts-Mills TA, Thomas WR, Aalberse RC et al:Dust mite allergens and asthma:report of a second international workshop. J Allergy Clin Immunol 89:1046-1060, 1992
PubMed
4) Sporik R, Chapman MD, Platts-Mills TA:House dust mite exposure as a cause of asthma. Clin Exp Allergy 22:897-906, 1992
PubMed
5) Platts-Mills TA, Pollart SM, Chapman MD et al:Role of allergens in asthma and airway hyperresponsiveness:relevance to immunotherapy and allergen avoidance. Asthma:Its Patholory and Treatment, ed by Kaliner MA, Barnes PJ, Persson CGA, Marcel Dekker, New York, 1991, pp595-631
 
6) Peat JK, Tovey E, Mellis CM et al:Importance of house dust mite and Alternaria allergens in childhood asthma:an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 23:812-820, 1993
PubMed
7) Rice JA, Pollock I, Little SA et al:Measurement of airborne mite antigen in homes of asthmatic children. Lancet 336:895-897, 1990
 
8) Plaschke P, Janson C, Balder B et al:Adult asthmatics sensitized to cats and dogs:symptoms, severity, and bronchial hyperresponsiveness in patients with furred animals at home and patients without these animals. Allergy 54:843-850, 1999
PubMed
9) Maeda Y, Kudoh M, Tomita S et al:[Annual change of the pet in allergic patients home for ten years]. [Japanese] Arerugi 48:27-32, 1999
PubMed
10) Suphioglu C, Singh MB, Taylor P et al:Mechanism of grass-pollen induced asthma. Lancet 339:569-572, 1992
PubMed
11) Pollart SM, Reid MJ, Fling JA et al:Epidemiology of emergency room asthma in northern California:association with IgE antibody to ryegrass pollen. J Allergy Clin Immunol 82:224-230, 1988
 
12) Garty BZ, Kosman E, Ganor E et al:Emergency room visits of asthmatic children, relation to air pollution, weather, and airborne allergens. Ann Allergy Immunol 81:563-570, 1998
PubMed
13) Busse W, Lemanske Jr RF, Stark JM et al:The role of respiratory infection in asthma, ed by Holgate ST et al, Asthma:Physiology, Immunopharmacology, and Treatment, Academic Press, London, 1993, pp 345-352
 
14) Nicholson KG, Kent J, Ireland DC:Respiratory viruses and exacerbations of asthma in adults. BM7307:982-986, 1993
PubMed
15) Kraft M, Cassell GH, Henson JE et al:Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 158:998-1001, 1998
PubMed
16) Allegra L, Blasi F, Centanni S et al:Acute exacerbations of asthma in adults:role of Chlamydia pneumoniae infection. Eur Respir J 7:2165-2168, 1994
PubMed
17) Blackie SP, Hilliam C, Village R et al:The time course of bronchoconstriction in asthmatics during and after isocapnic hyperventilation. Am Rev Respir Dis 142:1133-1136, 1990
PubMed
18) Newson R, Strachan D, Archibald E et al:Acute asthma epidemics, weather and pollen in England, 1987-1994. Eur Respir J 11:694-701, 1998
PubMed
19) 渡辺尚:日本人喘息患者のエタノール誘発気管支収縮の機序. アレルギー 40:1210-1217, 1991
 
20) Hunt LW Jr, Rosenow EC III:Drug induced asthma. In Bronchial asthma. Mechanisms and Therapeutics (3rd ed.), ed by Weiss EB, Stein M, Little Brown, Boston, 1993, pp621-631
 
21) Lehrer PM, Isenberg S, Hochron SM:Asthma and emotion:a review. J Asthma 30:5-21, 1993
PubMed
22) Chien SJ, Mintz S:Pregnancy and menses, in Bronchial Asthma. Mechanism Therapeutics (3rd ed.), ed by Weiss EB, Stein M, Little Brown, Boston, 1993, pp1085-1098
 
23) Barron WM, Leff AR:Asthma in pregnancy[editorial]. Am Rev Respir Dis 147:510-511, 1993
PubMed
24) Lazenby JP, Harding SM:Chronic cough, asthma, and gastroesophageal reflux. Current Gastroenterology Reports 2:217-223, 2000
PubMed
25) Wu DN, Tanifuji Y, Kobayashi H et al:Effects of esophageal acid perfusion on airway hyperresponsiveness in patients with bronchial asthma. Chest 118:1553-1556, 2000
PubMed
26) Rachelefsky GS, Katz RM, Siegel SC:Chronic sinus disease with associated reactive airway disease in children. Pediatrics 73:526-529, 1984
PubMed
27) Okayama M, Iijima H, Shimura S et al:Methacholine bronchial hyperresponsiveness in chronic sinusitis. Respiration 65:450-457, 1998
PubMed
P.67 掲載の参考文献
1) Welliver RC, Cherry JD:Bronchiolitis and infectious asthma. Textbook of infectious diseases 3rd, ed by Feigin RD, Cherry JD, Saunders, Philadelphia, 1992, pp245-254
 
2) 青木美奈子, 渡辺みづほ, 近藤直実ほか:発病早期よりデキサメサゾンを用いて良好な経過を得たアデノウイルス7型による脳炎を伴う肺炎の1例. 小児科診療 62:939-943, 1999
Medical*Online
3) Matsukura S, Kokubu F, Noda H et al:Expression of IL6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 98:1080-1087, 1996
PubMed
4) Karp CL, Wysocka M, Wahl LM et al:Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228-231, 1996
PubMed
P.71 掲載の参考文献
1) 相沢久道:喫煙の喘息に与える影響. 気道アレルギー'98, 冨岡玖夫ほか編, メディカルレビュー社, 東京, 1998, pp85-91
 
2) Bewley BR, Bland JM:Smoking and respiratory symptoms in two groups of schoolchildren. Prev Med 5:63-69, 1976
PubMed
3) Burrows B, Knudson RJ, Lebowitz MD:The relationship of childhood respiratory illness to adult obstructive airway disease. Am Rev Respir Dis 115:751-760, 1977
PubMed
4) Auerbach O, Hammond EC, Garfinkel L et al:Relation of smoking and age to emphysema. Whole-lung section study. N Engl J Med 286:853-857, 1972
PubMed
5) Lenz AG, Costabel U, Maier KL:Oxidized BAL fluid protein in patients with interstitial lung diseases. Eur Respir J 9:307-312, 1996
PubMed
6) Nadel JA, Commroe JH Jr:Acute effects of inhalation of cigarette smoke on airway conductance. J Appl Physiol 16:713-716, 1961
 
7) Aronson MD, Weiss ST, Ben RL et al:Association between cigarette smoking and acute respiratory tract illness in young adults. JAMA 248:181-183, 1982
PubMed
8) O'onnor GT, Sparrow D, Segal MR et al:Smoking, atopy, and methacholine airway responsiveness among middle-aged and elderly men. The Normative Aging Study. Am Rev Respir Dis 140:1520-1526, 1989
 
9) Burrows B, Halonen M, Lebowitz MD et al:The relationship of serum immunoglobulin E, allergy skin tests, and smoking to respiratory disorders. J Allergy Clin Immunol 70:199-204, 1982
PubMed
10) Taylor RG, Gross E, Joyce H et al:Smoking, allergy, and the differential white blood cell counts. Thorax 40:17-22, 1985
PubMed
11) Marquette CH, Saulnier F, Leroy O et al:Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 146:76-81, 1992
PubMed
12) Pedersen B, Dahl R, Karlstrom R et al:Eosinophil and neutrophilactivity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med 153:1519-1529, 1996
 
13) Weiss ST, Tager IB, Speizer FE et al:Persistent wheeze. Its relation to respiratory illness, cigarette smoking, and level of pulmonary function in a population sample of children. Am Rev Respir Dis 122:697-707, 1980
 
14) Tager IB, Weiss ST, Munoz A et al:Longitudinal study of the effects of maternal smoking on pulmonary function in children. N Engl J Med 309:699-703, 1983
PubMed
15) Schwartz J, Zeger S:Passive smoking, air pollution, and acute respiratory symptoms in a diary study of student nurses. Am Rev Respir Dis 141:62-67, 1990
 
16) Tager IB, Segal MR, Munoz A et al:The effect of maternal cigarette smoking on the pulmonary function of children and adolescents. Analyses of data from two populations. Am Rev Respir Dis 136:1366-1370, 1987
PubMed
17) White JR, Froeb HF, Kulik JA:Respiratory illness in nonsmokers chronically exposed to tobacco smoke in the work place. Chest 100:39-43, 1991
PubMed
18) Leuenberger P, Schwartz J, Ackermann-Liebrich U et al:Passivesmoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseasesin Adults, SAPALDIA Team. Am J Respir Crit Care Med 150:1222-1228, 1994
 
P.77 掲載の参考文献
1) Zhong NS:New insights into risk factors of asthma. Respirology 1:159-166, 1996
PubMed
2) Miyamoto T:Epidemiology of pollution-induced airway disease in Japan. Allergy 52:35-36, 1997
 
3) Soutar A, Seaton A, Brown K:Bronchial reactivity and dietary antioxidants. Thorax 52:166-170, 1997
PubMed
4) Nakano J, Yamashita N, Kuramochi H et al:Prevalence of bronchial asthma in adults increases in Japan-epidemiologic studies of asthma in Fujieda city in 1985 and 1988. Am J Respir Crit Care Med 161:A798, 2000
 
5) 公害健康被害補償予防協会報告 (http://www.kouken.or.jp)
 
6) Sagai M, Saito H, Ichinose T et al:Biological effects of diesel exhaust particles 1. In vitro production of superoxide and in vivo toxicity in mouse. Free Radic Biol Med 14:37-47, 1993
PubMed
7) Muranaka M, Suzuki S, Koizumi K et al:Adjuvant activity of diesel exhaust particulates for the production of IgE antibody in mice. J Allergy Clin Immunol 77:616-623, 1986
PubMed
8) Takafuji S, Suzuki S, Koizumi K et al:Diesel-exhaust particulates inoculated by the intranasal route have an adjuvant activity of IgE production in mice. J Allergy Clin Immunol 79:639-645, 1987
PubMed
9) Fujimaki H, Saneyoshi K, Nohara O et al:Intranasal instillation of diesel exhaust particulates and antigen in mice modulated cytokine productions in cervical lymph node cells. Int Arch Allergy Immunol 108:268-273, 1995
PubMed
10) Diaz-Sanchez D, Tsien A, Fleming J et al:Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a Thelper cell 2-type pattern. J Immunol 158:2406-2413, 1997
 
11) Diaz-Sanchez D, Dotson AR, Takenaka H et al:Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest 94:1417-1425, 1994
PubMed
12) Takano H, Yoshikawa T, Ichinose T et al:Diesel exhaust particules enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 156:36-42, 1997
 
13) Ohta K, Yamashita N, Tajima M et al:Diesel exhaust particulate induces airway hyperresponsiveness in a murine model:essential role of GM-CSF. J Allergy Clin Immunol 104:1024-1030, 1999
 
14) Ohtoshi T, Takizawa H, Okazaki H et al:Diesel exhaust particles stimulate human airway epithelial cells to produce cytokines relevant to airway inflammation in vitro. J AIIergy Clin Immunol 101:778-785, 1998
PubMed
15) Bayram H, Devalia JL, Sapsford RJ et al:The effect of diesel exhaust particles on cell function and release of inflammatory mediators from human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 18:441-448, 1998
PubMed
16) Bayram H, Devalia JL, Khair OA et al:Comparison of ciliary activity and inflammatory mediator release from bronchial epithelial cells of nonatopic nonasthmatic subjects and atopic nonasthmatic patients and the effect of diesel exhaust particles in vitro. J Allergy Clin Immunol 102:771-782, 1998
PubMed
17) Thurston GD, Ito K, Hayes CG et al:Respiratory hospital admissions and summertime haze air pollution in Toronto, Ontario:consideration of the role of acid aerosols. Environ Res 65:271-290, 1994
PubMed
18) Schwartz J, Dockery DW, Neas LM et al:Acute effects of summer air pollution on respiratory symptom reporting in children. Am J Respir Crit Care Med 150:1234-1242, 1994
PubMed
19) Romieu I, Meneses F, Ruiz S et al:Effects of air pollution on the respiratory health of asthmatic children living in Mexico City. Am J Respir Crit Care Med 154:300-307, 1996
PubMed
20) Delfino RJ:Symptoms in pediatric asthmatics and air pollution:differences in effects by symptom severity, anti-inflammatory medication use and particulate averaging time. Environ Health Perspect 106:751-761, 1998
PubMed
21) 小田嶋博, 広瀬隆二, 西間三馨:大気汚染物質 (浮遊粒子状物質, 二酸化窒素) と気管支喘息発作入院数との関連. アレルギー 44:160-169, 1995
 
22) Goldsmith CA, Kobzik L:Particulate air pollution and asthma:a review of epidemiological and biological studies. Rev Environ Health 14:121-134, 1999
PubMed
23) Koenig JQ:Air pollution and asthma. J Allergy Clin Immunol 104:717-722, 1999
PubMed
24) Svartengren M, Strand V, Bylin G et al:Sgort-term exposure to air pollution in a road tunnel enhances asthmatic response to allergen. Eur Respir J 15:718-724, 2000
 
25) Pope CA 3 rd, Dockery DW, Spengler JD et al:Respiratory health and PM 10 pollution. A daily time series analysis. Am Rev Respir Dis 144:668-674, 1991
 
P.85 掲載の参考文献
1) 東田有智, 南部泰孝, 田中明ほか:気管支喘息とストレスの関係. アレルギー 43:311, 1994
Medical*Online
2) 勝沼俊雄, 松原和樹, 飯倉洋治:小児気管支喘息とストレス. アレルギー科 2:1-5, 1996
 
3) Busse W W, Kiecolt-Glaser J K, Coe C et al:NHLBI Workshop summary. Stress and asthma. Am J Respir Crit Care Med 151:249-252, 1995
PubMed

PART 4 / 気管支喘息の診断

P.94 掲載の参考文献
1) 瀧島任:内科学の進歩, 気道過敏性の臨床. 日内会誌 76:20-25, 1987
 
2) 上田隆, 小林信之:気管支喘息の診断と鑑別のすすめかた, 臨床検査のすすめかた-血清学的検査.呼吸機能検査.吸入誘発誘験とその適応-. Med Pract 6:1813-1818, 1989
 
3) 牧野荘平:アレルギー性疾患, 2.気管支喘息. 臨床アレルギー学-アレルギー専門医・認定医研修のために, 宮本昭正監修, 南江堂, 東京, 1992, pp259-288
 
4) Ackerman V, Marini M, Vittori E et al:Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 105:687-696, 1994
PubMed
5) 江頭洋祐, 堀内正:成人喘息の診断. 気管支喘息とその周辺 (II) 成人気管支喘息の診断と治療, 宮本昭正監修, 現代医療社, 東京, 1995, pp23-48
 
6) Clinical Practice Guidelines of Asthma Treatment Guidelines for the Diagnosis and Management of Asthma NIH Publication No. 97 (4051):82-85, 108-113, 1997
 
7) 小川忠平, 佐野靖之:吸入β刺激薬, 吸入ステロイド薬併用と気道過敏性. アレルギー科5別刷:484-491, 1998
 
8) 佐野靖之:喘息の診断. Clinical Case-Oriented. -症例に学ぶ気管支喘息治療-, 足立満, 飯倉洋治, 佐野靖之ほか編集, メジカルビュー社, 東京, 2000, pp 4-7
 
P.106 掲載の参考文献
1) 藤村政樹:気道過敏性試験, 気道可逆性試験. 生体・機能検査のABC, 石井裕正, 工藤翔二, 矢崎義雄監修, 日本医師会, 東京, 1998, pp59-61
 
2) Fujimura M, Kamio Y, Hashimoto T et al:Log normal distribution of bronchial responsiveness to methacholine in normal young adults. Jpn J Physiol 43:541-552, 1993
PubMed
P.114 掲載の参考文献
1)American Thoracic Society:A statement by the commette on diagnostic standerds for non-tuberculous respiratory diseases, chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 85:762-768, 1962
 
2) 厚生省免疫.アレルギー研究班:喘息予防・管理ガイドライン1998, 牧野荘平, 古庄巻史, 宮本昭正監修, 共和企画通信, 東京, 1998, P3
 
3) 榊原博樹:喘鳴. 症候からみた診断へのアプローチ, 永井厚志, 大田健, 飛田渉編, メジカルビュー社, 東京, 2001, pp190-195
 
P.124 掲載の参考文献
1) 小児気管支喘息治療.管理ガイドライン, 2000年改訂版, 古庄巻史, 西間三馨監修, 協和企画, 東京, 2000
 
2) 厚生省免疫・アレルギー研究班:喘息予防・管理ガイドライン 1998, 牧野荘平, 古庄巻史, 宮本昭正監修, 協和企画通信, 東京, 1998
 
3) 森川昭廣, 岩田力, 永倉俊和:小児慢性特定疾患治療 (喘息) マニュアルの作成と医療意見書作成について, 厚生省心身障害研究. 効果的な小児慢性特定疾患治療研究事業の推進に関する研究 (班長柳澤正義) 報告書, 東京, 1998
 
4) 喘息の診断.管理. NIHガイドライン, 泉孝英, 大久保隆男監訳, 医学書院, 東京, 1999
 

PART 5 / 気管支喘息の日常管理法と治療への応用

P.134 掲載の参考文献
1) 喘息管理の国際指針. 喘息管理・予防のグローバルストラテジー-NHLBI/WHOワークショップレポート, 牧野荘平監修, 国際医学出版, 東京, 1995
 
2) 喘息教室, 石原享介編集, 新興医学出版社, 東京, 1999
 
3) 患者さんのための喘息学, 石原享介編集, 医薬ジャーナル社, 大阪, 1999
 
P.139 掲載の参考文献
1) 赤澤晃:患者主体のアレルギー医療を目指して～医師の立場から. ヘルスカウンセリング 3:43-46, 2001
 
2) 益子育代:患者主体のアレルギー医療を目指して～心理士の立場から. ヘルスカウンセリング 3:52-59, 2001
 
P.144 掲載の参考文献
1) NIH:Expert Panel Report 2, Guidelines for the Diagnosis and Management of Asthma, 1997, p146
 
2) 日本小児アレルギー学会:小児気管支喘息治療.管理ガイドライン 2000, 協和企画, 東京, 2000, pp94-95
 
3) 小児科サイドの患者教育の実際. アレルギー疾患の患者教育とコメディカルの参画, 宮本昭正, 石川哮, 飯倉洋治編, 医薬ジャーナル社, 大阪, 2000, pp67-71
 
4) 西藤成雄:ホームページを利用した喘息患者または家族への情報支援について. 日本小児アレルギー学会誌 14:201-211, 2000
 
P.150 掲載の参考文献
1) Peshkin M M:Asthma in children. Role of environment in the treatment of selected group cases:Aplea for a "home" as a restorative measure. Am J Dis Child 39:774-781, 1930
 
2) 遠城寺宗徳:小児喘息の治療. 小児科診察 22:575-578, 1959
 
3) 伊藤正寛, 井口光正, 内田幸憲:重症難治性喘息児の施設入院療法の検討. アレルギー 32:1099-1105, 1983
Medical*Online
4) 杉本日出雄, 白井康仁, 小幡俊彦:気管支喘息児に対する施設入院療法の身体面におよぼす効果. アレルギー 36:254-261, 198
 
5) 杉本日出雄, 松田秀一, 黒沼忠由樹ほか:気管支喘息児が重症化後, 早期に施設入院療法を行った場合の効果-共通指標を用いた多施設検討-. 日本小児アレルギー学会誌 9:282-288, 1995
 
6) 杉本日出雄, 松原和樹, 松田秀一ほか:施設入院療法の効果と予後に影響を与える因子. アレルギー 47:524-532, 1998
Medical*Online
P.155 掲載の参考文献
1) Burdon JGW, Juniper EF, Killian KJ et al:The perception of breathlessness in asthma. Am Rev Respir Dis 126:825-828, 1982
 
2) Nguyen BP, Wilson SR, German DF:Patient's perceptions compared with objective ratings of asthma severity. Ann Allerg y Asthma Immunol 77:209-215, 1996
 
3) Charlton I, Charlton G, Broomfield J et al:Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ 301:1355-1359, 1990
PubMed
4) Grampian Asthma Study of Integrated Car (GRASSIC):Effectiveness of routine self monitoring of peak flow in patients with asthma. BMJ 308:564-567, 1994
 
5) Jones KP, Mullee MA, Middleton M et al:Peak flow based asthma self-management:a randomized controlled study in general practice. Thorax 50:851-857, 1995
PubMed
6) National Heart, Lung, and Blood Institute. Statement on technical standards for peak flow meters. National Asthma Education Program, Expert Panel Report, November 14, 1990.
 
7) 喘息予防・管理ガイドライン 1998改訂版, 牧野荘平, 古庄巻史, 宮本昭正監修, 協和企画通信, 東京, 2000, pp77-78
 
8) International Consensus Report on Diagnosis and Management of Asthma. U. S. Department of Health and Human Services, Public Health Service, National Institutes of Health. Publication No. 92-3091, 1992.
 
9) Global Initiative for Asthma Management and Prevention. NHLBI/WHO. Workshop Report. National Institutes of Health. National Heart, Lung, and Blood Institute. Publication No. 95-3659, 1995.
 
10) Lahdensuo A, Haahtela T, Herrala J et al:Randomized comparison of guided self management and traditional treatment of asthma over one year. BMJ 312:748-752, 1996
PubMed
11) Buckknall CE, Slack R, Godley CC et al:Scottish Confidential Inquiry into Asthma Deaths (SCIAD), 1994-6. Thorax 54:978-984, 1999
 
12) Garrett J, Fenwick JM, Taylor G et al:Peak expiratory flow meters (PEFMs)-who uses them and how and does education affect the pattern of utilisation? Aust N Z J Med 24:521-529, 1994
PubMed
13) Kauppinen R, Vilkka V, Sintonen H et al:Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma. Respir Med 95:56-63, 2001
PubMed
14) Lopez-Vi?a A, del Castillo-Arevalo E:Influence of peak expiratory flow monitoring on an asthma self-management education programme. Respir Med 94:760-766, 2000
 
15) 月岡一治:成人喘息における患者教育と患者の自己管理. International Review Of Asthma 3:2-11, 2001
Medical*Online
16) Cote J, Cartier A, Robichaud P et al:Influence of asthma education on asthma severity, quality of life and environmental control. Can Respir J 7:395-400, 2000
 
P.162 掲載の参考文献
1) 西尾健:機能訓練メニューの施行とその評価並びに新規訓練事業の開発に関する研究. 公害健康被害補償予防協会委託業務報告書「地方公共団体における環境保健事業の効果的推進, 発展に関する研究報告書」1999年度西牟田研究班, 公害健康被害補償予防協会, 東京, 2000, pp201-205
 
2) 赤坂徹:気管支喘息の鍛錬療法. 小児医学 21:460-475, 1988
 
3) Godfrey S, Silverman M, Anderson SD:Problems of interpreting exercise-induced asthma. J Allergy Clin Immunol 52:199-209, 1973
PubMed
4) 三之宮愛雄:ユニホック. ぜん息児のための新しいスポーツ訓練のマニュアル, 公害健康被害補償予防協会, 東京, 2001 (印刷中)
 
5) 赤坂徹, 黒沼忠由樹, 白崎和也:スキー, スケート. ぜん息児のための新しいスポーツ訓練のマニュアル, 公害健康被害補償予防協会, 東京, 2001 (印刷中)
 

書評

最近チェックした商品履歴

Loading...